Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

NCT00647842 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Fentanyl Transdermal System 25 mcg/h + Bioclusive Overlay
DRUG: Fentanyl Transdermal System 25 mcg/h

Sponsor

Mylan Pharmaceuticals Inc